Erratum: Protein phosphatase magnesium-dependent 1A - Mediated inhibition of bmp signaling is independent of smad dephosphorylation (Journal of Bone and Mineral Research (2010) 25, (653-660) DOI: 10.1359/jbmr.090736);Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation

Journal of Bone and Mineral Research

Volumn 25, Issue 3, 2010, Pages 653-660

  Kokabu, Shoichiro ^a   Nojima, Junya ^a   Kanomata, Kazuhiro ^a   Ohte, Satoshi ^a   Yoda, Tetsuya ^a   Toru, Fukuda ^a   Katagiri, Takenobu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

BMP; Phosphatase; Phosphorylation; Proteasome; Smad

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; MAGNESIUM; MUTANT PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN PHOSPHATASE MAGNESIUM DEPENDENT 1A; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; UNCLASSIFIED DRUG; MDP-1 PROTEIN, MOUSE; PROTEIN PHOSPHATASE 2C;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA BINDING MOTIF; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE SILENCING; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MYOBLAST; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; IMMUNOHISTOCHEMISTRY; MICE; MYOBLASTS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD1 PROTEIN;

EID: 77953366105     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.179     Document Type: Erratum

References (33)

1. Katagiri T, Suda T, Miyazono K. The bone morphogenetic proteins. In: Derynck R, Miyazono K, eds. The TGF-β Family. Cold Spring Harbor, NY: Cold Spring Harbor Press, 2008:121-149.
2. Wan M, Cao X. BMP signaling in skeletal development. Biochem Biophys Res Commun 2005;328:651-657.
3. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005;16:251-263. (Pubitemid 40910315)
4. Lopez-Rovira T, Chalaux E, Massague J, Rosa JL, Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J Biol Chem 2002;277:3176-3185. (Pubitemid 34953179)
5. Liu CJ, Ding B, Wang H, Lengyel P. The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins. Mol Cell Biol 2002;22:2893-2905. (Pubitemid 34437449)
6. Katagiri T, Imada M, Yanai T, Suda T, Takahashi N, Kamijo R. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 2002;7:949-960.
7. Kaplan FS, Xu M, Seemann P, et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 2009;30:379-390.
8. Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006;38:525-527.
9. Fukuda T, Kohda M, Kanomata K, et al. Constitutively activated ALK2 and increased Smad1/5 cooperatively induce BMP signaling in fibrodysplasia ossificans progressiva. J Biol Chem. 2009;284:7149-7156.
10. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 2002;250:231-250. (Pubitemid 35216412)
11. Onichtchouk D, Chen YG, Dosch R, et al. Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 1999;401:480-485. (Pubitemid 29470206)
12. Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 1997;389:631-635. (Pubitemid 27446184)
13. Imamura T, Takase M, Nishihara A, et al. Smad6 inhibits signalling by the TGF-β superfamily. Nature 1997;389:622-626. (Pubitemid 27446182)
14. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999;400:687-693. (Pubitemid 129516185)
15. Sapkota G, Knockaert M, Alarcon C, Montalvo E, Brivanlou AH, Massague J. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-β pathways. J Biol Chem 2006;281:40412-40419. (Pubitemid 46041844)
16. Tamura S, Li G, Komaki K, Sasaki M, Kobayashi T. Roles of mammalian protein phosphatase 2C family members in the regulation of cellular functions. In: Alexander JAaDR, ed. Protein Phosphatases. Heidelberg: Springer-Verlag, 2003:91-105.
17. Duan X, Liang YY, Feng XH, Lin X. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 2006;281: 36526-36532. (Pubitemid 46042119)
18. Lin X, Duan X, Liang YY, et al. PPM1A functions as a Smad phosphatase to terminate TGFb signaling. Cell 2006;125:915-928. (Pubitemid 43795197)
19. Ishida W, Hamamoto T, Kusanagi K, et al. Smad6 is a Smad1/5-induced Smad inhibitor: characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 2000;275:6075-6079. (Pubitemid 30129890)
20. Goldman LA, Cutrone EC, Kotenko SV, Krause CD, Langer JA. Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. Biotechniques 1996;21:1013-1015.
21. Katagiri T, Yamaguchi A, Komaki M, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-1766. (Pubitemid 24380911)
22. Komaki M, Katagiri T, Suda T. Bone morphogenetic protein-2 does not alter the differentiation pathway of committed progenitors of osteoblasts and chondroblasts. Cell Tissue Res 1996;284:9-17. (Pubitemid 26106892)
23. Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K. Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors. J Biol Chem 2007;282:20603-20611. (Pubitemid 47100044)
24. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67:425-479.
25. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 1995;92:5249.
26. Ying SX, Hussain ZJ, Zhang YE. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. J Biol Chem 2003;278:39029-39036.
27. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 2007;25:441-454. (Pubitemid 46199289)
28. Jackson MD, Fjeld CC, Denu JM. Probing the function of conserved residues in the serine/threonine phosphatase PP2Cα. Biochemistry 2003;42:8513-8521.
29. Chacko BM, Qin B, Correia JJ, Lam SS, de Caestecker MP, Lin K. The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat Struct Biol 2001;8:248-253. (Pubitemid 32180052)
30. Knockaert M, Sapkota G, Alarcon C, Massague J, Brivanlou AH. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci USA 2006;103:11940-11945. (Pubitemid 44215790)
31. Pera EM, Ikeda A, Eivers E, De Robertis EM. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev 2003;17:3023-3028.
32. Kretzschmar M, Doody J, Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 1997;389:618-622. (Pubitemid 27446181)
33. Fukuda T, Kanomata K, Nojima J, et al. A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Biochem Biophys Res Commun 2008;377:905-909.